|
Private Placements (Details) (USD $)
|
0 Months Ended | 6 Months Ended | 0 Months Ended | 0 Months Ended | 1 Months Ended | 6 Months Ended | 0 Months Ended | 6 Months Ended | 0 Months Ended | 0 Months Ended | 6 Months Ended | 0 Months Ended | 0 Months Ended | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 20, 2012
|
Nov. 18, 2011
|
Oct. 28, 2011
|
Jun. 15, 2011
|
Sep. 30, 2012
|
Mar. 31, 2012
|
May 31, 2011
|
Oct. 28, 2011
Placement Agent [Member]
|
Nov. 18, 2011
The Warrants [Member]
|
Oct. 28, 2011
The Warrants [Member]
|
Oct. 28, 2011
The Warrants [Member]
Placement Agent [Member]
|
Jun. 15, 2011
Series A Common Stock Warrant [Member]
|
Jun. 15, 2011
Series B Common Stock Warrant [Member]
|
Jun. 15, 2011
Series C Common Stock Warrant [Member]
|
Oct. 28, 2011
Restricted Stock [Member]
Placement Agent [Member]
|
Aug. 31, 2011
Amendment Agreement [Member]
|
Sep. 30, 2012
Bridge Warrant [Member]
|
Jun. 22, 2011
Warrant [Member]
|
Sep. 30, 2012
Warrant [Member]
|
Jun. 02, 2011
Warrant [Member]
|
Sep. 30, 2012
Warrant [Member]
Placement Agent [Member]
|
Nov. 18, 2011
Common Stock [Member]
|
Oct. 28, 2011
Common Stock [Member]
|
Aug. 29, 2011
Bridge Debentures [Member]
|
Sep. 30, 2012
Bridge Debentures [Member]
The Warrants [Member]
|
Aug. 29, 2011
Bridge Debentures [Member]
Bridge Warrant [Member]
|
Aug. 29, 2011
Bridge Debentures [Member]
Warrant [Member]
|
Sep. 30, 2012
Bridge Debentures [Member]
Common Stock [Member]
|
Sep. 30, 2012
Rogai Note [Member]
|
Sep. 30, 2012
Rogai Note [Member]
The Warrants [Member]
|
Sep. 30, 2012
Rogai Note [Member]
Common Stock [Member]
|
Apr. 08, 2011
Octagon [Member]
|
Apr. 08, 2011
Octagon [Member]
Warrant [Member]
|
May 31, 2011
Octagon [Member]
Warrant [Member]
|
Apr. 08, 2011
Octagon [Member]
Common Stock [Member]
|
|
| Private Placement [Line Items] | |||||||||||||||||||||||||||||||||||
| Number of accredited investors | 20 | 6 | |||||||||||||||||||||||||||||||||
| Stock issued during the period | $ 292,500 | $ 292,500 | $ 146,250 | $ 146,250 | $ 292,500 | ||||||||||||||||||||||||||||||
| Warrants issuance | 585,000 | 1,164,375 | 2,869,688 | 2,869,688 | 1,171,875 | ||||||||||||||||||||||||||||||
| Proceeds from stock issuance, gross | 345,000 | 12,155,000 | 1,170,000 | 12,500,000 | |||||||||||||||||||||||||||||||
| Initial purchase price, per share | $ 4.0 | $ 2.0 | $ 2.0 | ||||||||||||||||||||||||||||||||
| Purchase price of stock, minimum | $ 2.0 | ||||||||||||||||||||||||||||||||||
| Exercise price of warrants | $ 1.0 | $ 0.8 | $ 1.0 | $ 1.0 | $ 1.0 | $ 3.0 | $ 5.0 | $ 10.0 | $ 4.0 | $ 0.82 | $ 3.15 | $ 0.64 | $ 0.8 | $ 1.0 | $ 1.0 | ||||||||||||||||||||
| Sales commission percentage | 10.00% | 10.00% | |||||||||||||||||||||||||||||||||
| Sales commission percentage for additional expenses | 2.00% | 2.00% | |||||||||||||||||||||||||||||||||
| Purchase percentage of number of shares to broker | 10.00% | ||||||||||||||||||||||||||||||||||
| Sales commission percentage of exercise of warrants | 10.00% | ||||||||||||||||||||||||||||||||||
| Gross proceeds from long term debt | 1,275,000 | 1,800,000 | |||||||||||||||||||||||||||||||||
| Interest rate | 12.00% | 12.00% | |||||||||||||||||||||||||||||||||
| Principal amount of debt | 1,800,000 | 107,000 | 750,000 | ||||||||||||||||||||||||||||||||
| Conversion of debt into equity, value | 4,000,000 | ||||||||||||||||||||||||||||||||||
| Conversion price percentage equal to percentage paid by investors | 80.00% | 80.00% | |||||||||||||||||||||||||||||||||
| Common stock, par value per share | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||||||||||||||||||||||||||
| Conversion price | $ 2.0 | $ 2.0 | $ 4.0 | ||||||||||||||||||||||||||||||||
| Maturity date | Mar. 01, 2012 | ||||||||||||||||||||||||||||||||||
| Unamortized discount on debt instrument | 244,000 | 1,556,289 | |||||||||||||||||||||||||||||||||
| Period of time for exercising | 5 years | 5 years | 5 years | 5 years | 3 years | ||||||||||||||||||||||||||||||
| Value used to determine exercise price if no qualified financing occured | 0.9 | ||||||||||||||||||||||||||||||||||
| Units issued, quantity | 6.9 | 243.1 | |||||||||||||||||||||||||||||||||
| Units issued, per unit value | 50,000 | ||||||||||||||||||||||||||||||||||
| Units issued conversion quantity of shares | 431,250 | 62,500 | 431,250 | 62,500 | |||||||||||||||||||||||||||||||
| Invested amount demonstration | 0.8 | ||||||||||||||||||||||||||||||||||
| Invested amount demonstration, quantity of equity received | 1 | 1 | |||||||||||||||||||||||||||||||||
| Private placement, net | $ 283,600 | $ 10,610,653 | |||||||||||||||||||||||||||||||||
| Stock issued during the period, shares | 15,193,750 | 100,000 | 15,194,695 | ||||||||||||||||||||||||||||||||
| Percentage of shares sold issued as commission | 10.00% | ||||||||||||||||||||||||||||||||||
| Debenture conversion price | $ 0.64 | ||||||||||||||||||||||||||||||||||
| Conversion of warrants, shares | 8,789,063 | 331,303 | 133,750 | 133,750 | 1,171,875 | 1,171,875 | |||||||||||||||||||||||||||||
| Disposition restriction period for executive officers | 270 days | ||||||||||||||||||||||||||||||||||
| Disposition period limiting the number of common stock or other securities by executive officers | 6 months | ||||||||||||||||||||||||||||||||||
| Maximum number of securities disposed of by officers, monthly | 5,000 | ||||||||||||||||||||||||||||||||||